CPT code 19330 represents the surgical removal of breast implant material in the setting of implant rupture. This code is used when explantation is performed to remove the implant and any associated leaked material, a clinically important intervention to address device failure, local inflammation, pain, or potential silicone migration. Nationally, explantation procedures for ruptured implants have implications for surgical utilization, device surveillance, and payer coverage policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how this service is classified, typical sites of service, and common clinical scenarios that prompt coding of 19330. The publication summarizes benchmark utilization metrics where available, typical billing practices, and relevant policy developments affecting coverage and prior authorization requirements.

The content provides practical context for coding and claims professionals, surgical teams, and policy analysts by outlining clinical indications, service settings, and payer considerations tied to explantation for ruptured breast implants. Data not available in the input is noted where applicable, and the focus remains on national-level implications rather than state-specific rules.